Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NOA-04 Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide

NCT00717210 is registered in ClinicalTrials.gov with Neuro-Oncology Working Group of the German Cancer Society as lead sponsor.

NCT NCT00717210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00717210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NOA-04 Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
Lead sponsor
Neuro-Oncology Working Group of the German Cancer Society
Phase
Phase 3
Overall status
Completed
Start date
June 30, 1999
Completion date
March 31, 2008
Enrollment
318 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, oligoastrocytoma, oligodendroglioma